Brief: Innate Pharma Posts H1 Net Income Of EUR 1.7 Mln

Innate Pharma SA

14/09/2023 06:05

Sept 14 (Reuters) - Innate Pharma SA  IPH.PA :
    * CASH POSITION OF EUR 124.7 MILLION(1) AS OF JUNE 30, 2023,
ANTICIPATED CASH RUNWAY INTO H2 2025
    * REVENUE AND OTHER INCOME FROM CONTINUING OPERATIONS
AMOUNTED TO
EUR 40.2M IN FIRST HALF OF 2023 (EUR 45.6M IN FIRST HALF OF
2022)
    * NET INCOME OF EUR 1.7M FOR FIRST HALF OF 2023 (NET INCOME
OF EUR
6.3M FOR FIRST HALF OF 2022).
    * H1 OPERATING LOSS EUR 0.4 MILLION VERSUS PROFIT EUR 8.5
MILLION
YEAR AGO

Source text for Eikon:  ID:nBw8TBH3Da 
Further company coverage:  IPH.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))